AM MEDICA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AM MEDICA
Largest movements
- Receivables within one year +€30,679
up €30,679 (+194%), from €15,852 to €46,531
of which Other amounts receivable: +€20,229
- Cash -€4,308
down €4,308 (-33.5%), from €12,863 to €8,555
mainly Receivables within one year (-€30,679) and Other debts (-€652)
- Deferred charges and accrued income -€1,304
no longer reported in 2025 (was €1,304)
- Profit (loss) carried forward +€20,234
up €20,234 (+91.8%), from €22,053 to €42,287
- Tax, wage and social debts +€5,176
up €5,176 (+70.8%), from €7,310 to €12,486
- Other debts -€652
no longer reported in 2025 (was €652)
- Other operating charges +€504
up €504 (+798%), from €63 to €567
- Financial income +€386
new in 2025: €386
- Taxes +€363
up €363 (+5.9%), from €6,153 to €6,517
- Gross operating margin +€287
up €287 (+1.0%), from €27,849 to €28,136
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €31,705 | €56,330 | +€24,625 | +77.7% |
| Fixed assets | 21/28 | €1,686 | €1,243 | -€443 | -26.3% |
| Tangible fixed assets | 22/27 | €1,686 | €1,243 | -€443 | -26.3% |
| Furniture and vehicles | 24 | €1,686 | €1,243 | -€443 | -26.3% |
| Current assets | 29/58 | €30,019 | €55,086 | +€25,067 | +83.5% |
| Amounts receivable within one year | 40/41 | €15,852 | €46,531 | +€30,679 | +194% |
| Trade receivables | 40 | €15,852 | €26,302 | +€10,449 | +65.9% |
| Other amounts receivable | 41 | - | €20,229 | +€20,229 | |
| Cash at bank and in hand | 54/58 | €12,863 | €8,555 | -€4,308 | -33.5% |
| Deferred charges and accrued income | 490/1 | €1,304 | - | -€1,304 | |
| Total equity and liabilities | 10/49 | €31,705 | €56,330 | +€24,625 | +77.7% |
| Equity | 10/15 | €23,053 | €43,287 | +€20,234 | +87.8% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Contributions outside capital | 11 | €1,000 | €1,000 | = | 0.0% |
| Other | 1109/19 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €22,053 | €42,287 | +€20,234 | +91.8% |
| Amounts payable | 17/49 | €8,652 | €13,042 | +€4,390 | +50.7% |
| Amounts payable within one year | 42/48 | €8,652 | €13,042 | +€4,390 | +50.7% |
| Trade debts | 44 | €690 | €556 | -€134 | -19.4% |
| Suppliers | 440/4 | €690 | €556 | -€134 | -19.4% |
| Taxes, remuneration and social security | 45 | €7,310 | €12,486 | +€5,176 | +70.8% |
| Taxes | 450/3 | €7,310 | €12,486 | +€5,176 | +70.8% |
| Other amounts payable | 47/48 | €652 | - | -€652 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €507 | €443 | -€65 | -12.7% |
| Other operating charges | 640/8 | €63 | €567 | +€504 | +798% |
| Gross operating margin | 9900 | €27,849 | €28,136 | +€287 | +1.0% |
| Operating profit (loss) | 9901 | €27,278 | €27,127 | -€152 | -0.6% |
| Financial income | 75/76B | - | €386 | +€386 | |
| Recurring financial income | 75 | - | €386 | +€386 | |
| Financial charges | 65/66B | €576 | €762 | +€185 | +32.1% |
| Recurring financial charges | 65 | €576 | €762 | +€185 | +32.1% |
| Profit (loss) for the period before taxes | 9903 | €26,702 | €26,751 | +€49 | +0.2% |
| Income taxes | 67/77 | €6,153 | €6,517 | +€363 | +5.9% |
| Profit (loss) for the period | 9904 | €20,549 | €20,234 | -€314 | -1.5% |
| Profit (loss) for the period to be appropriated | 9905 | €20,549 | €20,234 | -€314 | -1.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.